chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I am COVID-19 positive right now; I am COVID-19 positive right now; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset May2023, outcome "unknown" and all described as "I am COVID-19 positive right now". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2023) Positive, notes: I am COVID-19 positive right now.  Clinical course: Patient was COVID-19 positive right now, patient was back vaccinated it was Pfizer vaccine the first two vaccines (Clarified as Pfizer COVID-19 Vaccine) then got a booster when they were recommended the Booster shot (Clarified as Pfizer COVID-19 Vaccine Booster) that was Jan2022, and wanted to know how good is this vaccines this is, for how long this going to expire or should got in. Also, wanted to know considered himself fully vaccinated or just other 4 vaccine that need to get it again or there is more vaccines.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Reports mild swelling & erythema, quarter sized to R deltoid. Denies pain at site.
paresthesia of 4 & 5th digits of rt hand w/tender non-palpable axillary lymph node;30NOV94 f/u paresthesia resolved on 12NOV94 rt axillary tenderness resolved 15NOV94;
I received my 1st dose 7 wks ago on 05May2021.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I received my 1st dose 7 wks ago on 05May2021.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (I received my 1st dose 7 wks ago on 05May2021.). On 22-Jun-2021, PRODUCT DOSE OMISSION ISSUE (I received my 1st dose 7 wks ago on 05May2021.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Starting around 10/04/2022, I developed an infection in the right sublingual salivary gland. I was treated with AUGMENTIN BID x 7 days. It cleared up with that treatment. On 11/06/2022, I got another infection in my right submandibular salivary gland. I called the doctor and she thought it was in my parotid gland as well. I went and got a CT scan of my face and neck yesterday and, was started on clindamycin QID x 10 days. The CT scan indicated the infection was only in the salivary gland (submandibular). I have never had this issue before receiving the vaccines.
Patient developed an area 3" x 2" around the site of the injection. It is raised, red and mildly warm to the touch probable cellulitis, possible drug reaction or interaction or allergic reaction. Patient placed on Doxycycline 50 mg bid & CLARITIN 10 mg daily.
This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heartbeat that lasted for 6 hours) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HEART RATE INCREASED (rapid heartbeat that lasted for 6 hours). On 18-Mar-2021, HEART RATE INCREASED (rapid heartbeat that lasted for 6 hours) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication were provided. Company comment: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of heart rate increased, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of heart rate increased, a causal relationship cannot be excluded.
The patient originally received first dose of covid-19 vaccine on 2/11/21. Patient inadvertently given one manufacturer covid vaccine at the second dose on 03/24/21 other vaccine. Patient reported no symptoms and in addition was evaluated/assessed by physician, Dr. . Upon discharge, patient exhibited no adverse reactions or distress. Dr. followed up with patient on 03/25/21 via telephone and patient reported no reaction or issues.
Information has been received from a registered nurse referring to multiple unspecified patients of unknown age and gender. On unknown dates, the patients were vaccinated with (Oka-Merck) PROQUAD (lot # K011311, expiration date 14-FEB-2016; Lot# L024122, Expiration date 30-DEC-2016; dose, route not provided). They were improperly stored. No adverse effects were reported. This was one of several reports received from the same source. Additional information has been requested.
Almost passed out after injection. Had immediate disorientation, head pressure, ear ringing, and slight hearing loss. I stayed 1 hour after at facility . The next day disorientation was better. The head pressure was better after 2 weeks. The hearing loss has slightly improved. The ear ringing worsened significantly and is still going on now, 9 weeks later. It has improved some now after seeing an ENT ear specialist. I have been taking medicine to try to help the ear ringing for about 7 weeks. The severity of the ear ringing has gone from an 8 out of 10 in loudness to about a 2. It is not gone and may never go away.
WHOLE BODY HURT; CHILLS; FEVER; BAD HEADACHE; PAIN MOVING DOWN ARM AS THE SHOT GIVEN; This spontaneous report received from a patient via a company representative concerned a 50 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 202A21A, and expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 16:30 for prophylactic vaccination. No concomitant medications were reported.  On 06-APR-2021, the subject experienced pain moving down arm as the shot given. On 07-APR-2021, the subject experienced whole body hurt. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced bad headache. On 07-APR-2021 18:00, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from whole body hurt, pain moving down arm as the shot given, chills, fever, and bad headache. This report was non-serious.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Nausea-Severe, Additional Details: Patient is reporting extreme nausea, diziness, and fatigue.  Patients activity level has decreased since recivieng 2nd booster.  Symptoms started 2 days following vaccination & patient is reporting still occuring at 4 days post vaccination.  Recommended to go to see primary care provider tomorrow if symptoms still occuring.
5/18/00 site red, elevated, itchy. 5/21/00 rash developed on back, in arm pit, very itchy at arm, very sore and itchy. Rash red and elevated but not pustular. Only one lesion on face broken.
I have had a rash on the inside of my arm at the elbow area since getting the first shot. I am not sure if is linked to my psoriasis, but that is pretty dormant at this point. I got my second dose last week Thursday in the opposite arm, and I have not had any issues arise yet.
Initial and follow-up information has been received from a physician concerning a patient who was inadvertently vaccinated with a dose of Pneumovax 23 instead of a fourth dose of PREVNAR.  The physician stated that there was an error on the part of the office.  Specifically, 70 doses of Pneumovax 23 (MSD) were ordered instead of PREVNAR because both products were next to each other on the order form.  It was reported that 40 doses were administered with the belief that they were PREVNAR.  It was reported that there was no confusion in regards to product packaging.  The physician stated that the problem had been corrected at the office and did not foresee any future problems.  On an unspecified date, the patient was vaccinated with a fourth dose of PREVNAR.  There were no adverse experiences reported.  Follow-up reported that the patient had "done well" and no pneumococcal infection had been noted.  Additional information is not expected.
I have a red blotchy arm 2 days after the moderna vaccine?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (I have a red blotchy arm 2 days after the moderna vaccine?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH MACULAR (I have a red blotchy arm 2 days after the moderna vaccine?). At the time of the report, RASH MACULAR (I have a red blotchy arm 2 days after the moderna vaccine?) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were mentioned. No treatment details were reported.
Soreness, slight erythema, Induration size is 3 1/2 x 3 1/4, warm to touch  No fever Follow up PCP/ urgent care Recommended anti-inflammatory medication, cool compresses
Information has been received from a consumer concerning her granddaughter, a female patient who was vaccinated with GARDASIL (lot number, route and site not reported). Subsequently the patient became violently ill. It was unknown if the patient sought medical attention. The patient's outcome was unknown. No further information is available.
PATIENT DEVELOPED A CHRONIC COUGH AND SEVERE MUSCLE ACHES WITHIN 48 HOURS OF MODERNA DOSE 2
No adverse event; Patient received second shot of primary series in another state but again received second shot as she did not remember when and where she received vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXTRA DOSE ADMINISTERED (Patient received second shot of primary series in another state but again received second shot as she did not remember when and where she received vaccine) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Patient received second shot of primary series in another state but again received second shot as she did not remember when and where she received vaccine) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (Patient received second shot of primary series in another state but again received second shot as she did not remember when and where she received vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (Patient received second shot of primary series in another state but again received second shot as she did not remember when and where she received vaccine).    No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
On 10/31/23, a 9yo patient received 0.5mL of the COVID Moderna Vaccine for 6mo-11yo as dose #4 (instead of the intended 0.25mL) due to the misunderstanding that the vial had no more than 0.25mL. This is reported as a vaccination dose error.
Rash (urticaria) noted on face.  Lasted 3 days.  No shortness of breath or difficulty swallowing.  Subsequently tested positive for Covid 19 on 1/15 (mild to moderate symptoms)
This spontaneous report was received from a medical assistant regarding a 4 year old patient of unknown gender. There was no information about concurrent condition and historical medication. On 01-SEP-2016 the patient was vaccinated with expired M-M-R II, 0.5 ml, subcutaneous, lot # M001200/ expiration date-28-AUG-2016. No adverse event was reported. The outcome of event was unknown. No PQC (product quality complaint) was involved. Additional information has been requested.
pt recvd vax;4 days later,c/o rash on arms,spreading to abd w/ fever 101,lasted 3 days;joints hurt at time of fever,wrist swollen/hurt joints;pt said rt hand stays colder;c/o inc problems w/ rt hand;pain getting worse & swelling inc;
Suspected vaccination failure; shingles in Feb 2020 / in June of 2020 / now has shingles for a third time; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 60-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix (intramuscular) .5 ml. On 1st February 2020, unknown after receiving Shingrix and less than a year after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose in summer of 2019 in left arm. After receiving 2nd dose of Shingrix, the patient experienced his first case of shingles in February 2020, his second case in June 2020 and at the time of reporting he had shingles for a third time. The reporter did not consent to follow up. This case was considered as suspected vaccination failure, since laboratory confirmation for herpes zoster were not provided.
allergic reaction, my eyes, ears burn,  lips swollen ,stomach hurt and throat felt like I had hair ball , dry mouth , and it became hard to swallow and my voice became horse .
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. In 2016, the patient was inoculated with ZOSTAVAX, (lot# and route unknown), at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2016, the patient was treated by a physician, at a health facility/office, for the onset of a severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
UNKNOWN . COULD NOT GET HOLD OF THE PATIENT WITH THE PHONE NUMBBER LISTED ON THE FORM. LEFT MESSAGES FOR PATIENT
Developed a "knot" at injection site. Began to experience pain radiating through scapula, shoulder area on injection site side.
memory loss; walking but not going anywhere; waving her hands as if playing the piano; headache; shivering; This spontaneous case was reported by a consumer and describes the occurrence of   in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event was reported).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment information was not provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Chills; Aching all over body; Joint pain; Cold like symptoms similar to flu; Little bit bruised arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), MYALGIA (Aching all over body), ARTHRALGIA (Joint pain), INFLUENZA LIKE ILLNESS (Cold like symptoms similar to flu) and INJECTION SITE BRUISING (Little bit bruised arm at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced CHILLS (Chills), MYALGIA (Aching all over body), ARTHRALGIA (Joint pain), INFLUENZA LIKE ILLNESS (Cold like symptoms similar to flu) and INJECTION SITE BRUISING (Little bit bruised arm at the injection site). At the time of the report, CHILLS (Chills), MYALGIA (Aching all over body), ARTHRALGIA (Joint pain), INFLUENZA LIKE ILLNESS (Cold like symptoms similar to flu) and INJECTION SITE BRUISING (Little bit bruised arm at the injection site) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment Medication was Provided. No Concomitant Drug was Provided.
soreness in my arm.  It was the worse the first few days as expected, then improved some over the first week.  Now at 2 1/2 weeks, it is still very sore when I lift my arm up over my head.  Everything I read sounded as if the soreness should have gone away after a few days.    It is sometimes sore to the touch and sometimes I wake up at night after lying on that side and it is really sore.  The worse pain though is definitely when I try to use my arms to lift a shirt off up over my head.  I have been taking Tylenol to help the pain.
no problem w/vax until 10/7/99 & devel soreness, redness & heat below inj site;70x110mm of redness w/ sl heat & swelling;
The first 24 hours my arm was really sore and I was fatigued. My arm slowly stopped being sore after a few days. 9 days later my arm was  itchy and a little tender. The next day I noticed a rash about 4? long and 2.5? wide.
reported hives on left thigh and left abdomen  took benadryl 25 mg approx 9 pm 9/15/20  no hives 9/16/20
On 3/24 by 9:25 PM I had mild shakes. At about 10:00 PM my lips stared to tingle and become numb. Subsequently I began to have difficulty swallowing as well as experiencing some sub sternal pain. Went to get my Epipen and put it beside me in bed. Difficulty swallowing got a bit worse but as I was not experiencing shortness of breath I held off the Epinephrine injection. (What on earth was I thinking?!)The "semi anaphylaxis" was self limiting and by 11:00 PM symptoms had subsided completely. But by approximately 11:30 MP I had severe rigors lasting about 3 - 5 minutes. On 3/25 I developed a severe headache and a low grade T (T-max 99.9). Took Tylenol 825mg with good effect. The following night I had severe night sweats, drenching 3 sets of pajamas. Today, on 3/26 I have been experiencing several cold sweats and I am altogether feeling "strange" (can't put my finger on it - maybe dehydration?). Have vegan to aggressively hydrate. Notified my Primary Care Physician's office. Agreed to "ride it out" for now. Shall see my PPP on
Headaches on and off; Itchy; Rash on my abdomen, back, legs and arms.; This is a spontaneous report from a contactable consumer (patient).  A 63-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation solution for injection; Lot number: EP7533), via an unspecified route of administration on 31Mar2021 10:00, as single in Arm Left, for covid-19 immunization. Prior to vaccination, the patient was not diagnosed with covid-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient's medical history was not reported. The patient's concomitant medications included loratadine, pseudoephedrine sulfate (CLARITIN-D) and vitamins. Past drug events included Celebrex and Doxycycline with known allergies. On 04Apr2021 14:00, the patient experienced headaches on and off; itchy; and rash on my abdomen, back, legs and arms. The patient did not receive treatment for the reported events. The outcome of the events was not resolved.   No follow attempts are possible. No further information is expected.
Area has been sore since the shot, which is to be expected,   However, it's been two weeks and now I am getting redness in the area and it feels hot, similar to my cellulitis infections I get in my right arm, but that one has lympedema and my left arm does not and should be fine.  It feels like an infection.  I marked the redness to see if it grows.
Became very dizzy and nauseous 30 minutes after the vaccine was given while sitting in the lobby. Suddenly I could hear my heartbeat very loudly in the ears and felt as though I was going to faint. My breath became shallow and I felt as though I was going to vomit and that my heart was racing. I started having difficulty focusing my eyes.
BODY ACHES; CHILLS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry: UNKNWON) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced chills, and body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and body aches was not reported. This report was non-serious.